apl. Prof. Dr. Abbas Agaimy

Medizinische Fakultät Institute of Pathology

Comparison of the 7th and revised 8th UICC editions (2020) for oral squamous cell carcinoma: How does the reclassification impact staging and survival? (2024) Struckmeier AK, Eichhorn P, Agaimy A, Buchbender M, Möst T, Lutz R, Kesting MR Journal article FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity (2024) Agaimy A, Antonescu CR, Bell D, Breimer GE, Dermawan JK, Kester LA, Laco J, et al. Journal article Uterine mesenchymal tumours harboring the KAT6B/A::KANSL1 gene fusion represent a distinct type of uterine sarcoma based on DNA methylation profiles (2024) Kommoss FK, Charbel A, Kolin DL, Howitt BE, Köbel M, Lee JC, McCluggage WG, et al. Journal article ALK -rearranged Mesenchymal Neoplasms With Prominent Foamy/Pseudolipogenic Cell Morphology : Expanding the Phenotypic Spectrum of ALK Fusion Neoplasms and Report of Novel Fusion Partners. (2024) Agaimy A, Stöhr R, Fisher C, Chrisinger JS, Demicco EG, Tögel L, Michal M, Michal M Journal article Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): what do we need to know? (2024) Coca-Pelaz A, Rodrigo JP, Agaimy A, Hartl DM, Stenman G, Vander Poorten V, Mäkitie AA, et al. Journal article, Review article Chronic hearing loss turns out being a calcified chondroid mesenchymal neoplasm with FN1::FGFR2 fusion (2024) Bauerschmitz L, Agaimy A, Eckstein M, Balk M, Iro H, Schleder S, Schlaffer SM, Gostian AO Journal article Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites (2024) Agaimy A, Blakely M, Breimer GE, Hölsken A, Koppes SA, Meidenbauer N, Rijken JA, et al. Journal article Conventional (bone-type) giant cell tumor of the larynx: the first case with proven H3-3A: c.103G >T (p.Gly35Trp) mutation (2024) Laco J, Vosmikova H, Satankova J, Dedkova J, Mejzlik J, Chrobok V, Agaimy A Journal article Molekulare Testung bei mesenchymalen Neoplasien: Was, wann und wie testen? Eine Übersicht mit besonderem Fokus auf den Stellenwert der Next-Generation-Immunhistochemie als Alternative für molekulare Testung (2024) Agaimy A Journal article A Firing Cannon: Bilateral Lower Limb Ischemia as a Manifestation of Cardiac Myxoma. (2024) Elbayomi M, Groß R, Presheet P, Agaimy A, May M, Wayend M, Heim C Journal article